Atlas Trials

Study on Tolerability of Repeat i.c.v. Administration of sNN0031 Infusion Solution in Patients With PD

Clinical trial NCT02408562 · TERMINATED

Trial details

NCT number
NCT02408562
Sponsor
Newron Sweden AB
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Parkinson's Disease
Start date
2015-01-01
Primary completion
2015-10-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.